Business Today: Latest Business News, India economy News, Stock Markets, Sensex, Mutual Funds and Indian Tax
Loading...
Search

Total 340 results found. Search for [ Zydus ]

Results 1 to 21 of 340
BusinessToday.In
July 4, 2020
ICMR assured that the fast-tracked vaccine development process adheres to globally accepted norms while negating hindrances due to red tape and \"slow file movement\"


PB Jayakumar
New Delhi, July 3, 2020
Industry experts say this could be only an aspirational target and directive to speed up the trials, than a realistic move to get the vaccine launched within one and a half months


BusinessToday.In
July 3, 2020
Cadila Healthcare stock trades mere points away from its 52-week high of Rs 383.65. Cadila Healthcare stock has risen 4.73% in the last 2 sessions


BusinessToday.In
July 3, 2020
Coronavirus vaccine update: A coronavirus vaccine candidate tested by American firm Pfizer and German biotech major BioNTech SE has been found to generate antibodies in people, a study showed


E Kumar Sharma
July 3, 2020
Zydus Cadila is second in India after Bharat Biotech to receive DCGI nod for human trials of vaccine candidate


www.businesstoday.in
New Delhi, July 3, 2020
 Intel Capital, an investment arm of Intel Corporation, will invest Rs 1,894.50 crore in Jio Platforms at an equity value of Rs 4.91 lakh crore and an enterprise value of Rs 5.16 lakh crore. Intel Capital's investment will translate into a 0.39% equity stake in Jio Platforms on a fully diluted basis; Indian government on Thursday approved the purchase of 33 Russian fighter jets and upgrades to another 59 planes, acting to beef up its air force at a time when the military is locked in a border stand-off with China; Zydus Cadila Healthcare has received approval from the Drug Controller General of India (DCGI) for human trials of its coronavirus vaccine candidate. This is the second vaccine candidate to be approved for human trials in India after Hyderabad-based Bharat Biotech's COVAXIN. Watch this and more news on News Blast.Bank credit grows 6.18%, deposits 11% in fortnight ended June 19


BusinessToday.In
July 3, 2020
Coronavirus treatment: FIR filed against Nanavati hospital. \"We are awaiting the copy of the complaint to scrutinise the bill,\" said the hospital


BusinessToday.In
New Delhi, July 3, 2020
Intel Capital to pump in Rs 1,894.5 cr in Jio Platforms; 12th investment in 11 weeksIntel Capital, investment arm of Intel Corporation, will invest Rs 1,894.50 crore in Jio Platforms at an equity value of Rs 4.91 lakh crore and an enterprise value of Rs 5.16 lakh crore. Intel Capital's investment will translate into a 0.39% equity stake in Jio Platforms on a fully diluted basis. Intel Capital joins the list of marquee firms that have recently invested in Jio Platforms, taking the ...


BusinessToday.In
July 3, 2020
The rupee opened at 74.60 per US dollar, registering a jump of 44 paise over its previous close of 75.01 per dollar on Thursday


Reuters
July 3, 2020
Although improved from May, sub-indexes showed domestic and foreign demand continued to decline sharply leading firms to cut jobs for the fourth straight month in June


BusinessToday.In
July 3, 2020
Maharashtra Mumbai, Delhi Coronavirus (COVID-19) cases, Lockdown News Pune, Thane Live Updates: ICMR writes to Bharat Biotech to conclude trials of COVID-19 vaccine in order to launch the results by August 15. India's total coronavirus cases jumped to 6,25,544 on Friday. Maharashtra's tally is past 1.86 lakh while Tamil Nadu and Delhi count stands at 98,392 and 92,175


BusinessToday.In
July 3, 2020
Coronavirus vaccine update: The DCGI approved the vaccine candidate for human trials after Zydus Cadila's candidate was found to be safe. The company is likely to start enrolment of subjects soon


Rupa Burman Roy
July 3, 2020
Stocks to watch today on July 3: Cadila, Muthoot Finance, Axis Bank, Affle India, HDFC Life among others are the top stocks to watch out for Friday's trading session.


Reuters
July 3, 2020
\"Three are really, really looking good,\" Trump said at an event at the White House, without providing details


PTI
July 3, 2020
Coronavirus vaccine update: The approval process was fast-tracked following a recommendation by the subject expert committee on COVID-19, considering the emergency and unmet medical need during the pandemic


E Kumar Sharma
July 1, 2020
Bharat Biotech isn't committing a timeline, but considering the necessary processes, and if COVAXIN does not fail at any stage, the earliest it could hit the market is late 2021


BusinessToday.In
New Delhi, June 28, 2020
While the general opinion of most experts and pharmaceutical companies is that a corona vaccine would be ready by mid-2021, researchers are still hoping for a 2020 breakthrough


BusinessToday.In
New Delhi, June 26, 2020
Coronavirus vaccine update: Moderna has signed a deal with Catalent for large-scale manufacturing of its vaccine candidate. Catalent will provide vial filling and packaging capacity as well as additional workforce required for 24X7 manufacturing operations.


PB Jayakumar
June 24, 2020
Remdesivir, allowed for emergency use in COVID-19 patients from May 1, is currently given as an injection and can be used only in hospitals


PB Jayakumar
June 19, 2020
The move comes after an inter-ministerial High-Level Empowered Committee assessment that the number of manufacturing units of HCQ have increased three times


PAGES 1 OF 17  12345